353 related articles for article (PubMed ID: 11585338)
1. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis.
Borton AJ; Frederick JP; Datto MB; Wang XF; Weinstein RS
J Bone Miner Res; 2001 Oct; 16(10):1754-64. PubMed ID: 11585338
[TBL] [Abstract][Full Text] [Related]
2. Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta.
Yang YA; Tang B; Robinson G; Hennighausen L; Brodie SG; Deng CX; Wakefield LM
Cell Growth Differ; 2002 Mar; 13(3):123-30. PubMed ID: 11959813
[TBL] [Abstract][Full Text] [Related]
3. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
Alvarez J; Serra R
Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
[TBL] [Abstract][Full Text] [Related]
4. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.
Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y
Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953
[TBL] [Abstract][Full Text] [Related]
5. Smad3 has a critical role in TGF-beta-mediated growth inhibition and apoptosis in colonic epithelial cells.
Mithani SK; Balch GC; Shiou SR; Whitehead RH; Datta PK; Beauchamp RD
J Surg Res; 2004 Apr; 117(2):296-305. PubMed ID: 15047135
[TBL] [Abstract][Full Text] [Related]
6. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice.
Nissen-Meyer LS; Jemtland R; Gautvik VT; Pedersen ME; Paro R; Fortunati D; Pierroz DD; Stadelmann VA; Reppe S; Reinholt FP; Del Fattore A; Rucci N; Teti A; Ferrari S; Gautvik KM
J Cell Sci; 2007 Aug; 120(Pt 16):2785-95. PubMed ID: 17652162
[TBL] [Abstract][Full Text] [Related]
7. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
8. Deletion of membrane-bound steel factor results in osteopenia in mice.
Lotinun S; Evans GL; Turner RT; Oursler MJ
J Bone Miner Res; 2005 Apr; 20(4):644-52. PubMed ID: 15765184
[TBL] [Abstract][Full Text] [Related]
9. Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast.
Hendy GN; Kaji H; Sowa H; Lebrun JJ; Canaff L
Horm Metab Res; 2005 Jun; 37(6):375-9. PubMed ID: 16001330
[TBL] [Abstract][Full Text] [Related]
10. Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation.
Feinberg MW; Shimizu K; Lebedeva M; Haspel R; Takayama K; Chen Z; Frederick JP; Wang XF; Simon DI; Libby P; Mitchell RN; Jain MK
Circ Res; 2004 Mar; 94(5):601-8. PubMed ID: 14752027
[TBL] [Abstract][Full Text] [Related]
11. The ratio of osteocytic incorporation to bone matrix formation in femoral neck cancellous bone: an enhanced osteoblast work rate in the vicinity of hip osteoarthritis.
Jordan GR; Loveridge N; Power J; Clarke MT; Parker M; Reeve J
Calcif Tissue Int; 2003 Mar; 72(3):190-6. PubMed ID: 12532281
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
14. Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio.
Wiren KM; Toombs AR; Semirale AA; Zhang X
Bone; 2006 May; 38(5):637-51. PubMed ID: 16413235
[TBL] [Abstract][Full Text] [Related]
15. Role of Smad3, acting independently of transforming growth factor-beta, in the early induction of Wnt-beta-catenin signaling by parathyroid hormone in mouse osteoblastic cells.
Inoue Y; Canaff L; Hendy GN; Hisa I; Sugimoto T; Chihara K; Kaji H
J Cell Biochem; 2009 Sep; 108(1):285-94. PubMed ID: 19582775
[TBL] [Abstract][Full Text] [Related]
16. Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway.
Kaji H; Naito J; Inoue Y; Sowa H; Sugimoto T; Chihara K
Horm Metab Res; 2008 Nov; 40(11):746-51. PubMed ID: 18622892
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.
Masuyama R; Stockmans I; Torrekens S; Van Looveren R; Maes C; Carmeliet P; Bouillon R; Carmeliet G
J Clin Invest; 2006 Dec; 116(12):3150-9. PubMed ID: 17099775
[TBL] [Abstract][Full Text] [Related]
18. Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis.
Li AG; Lu SL; Zhang MX; Deng C; Wang XJ
Cancer Res; 2004 Nov; 64(21):7836-45. PubMed ID: 15520189
[TBL] [Abstract][Full Text] [Related]
19. TGF-β-related mechanisms of bone destruction in multiple myeloma.
Matsumoto T; Abe M
Bone; 2011 Jan; 48(1):129-34. PubMed ID: 20570621
[TBL] [Abstract][Full Text] [Related]
20. Osteoblastic molecular scaffold Gab1 is required for maintaining bone homeostasis.
Weng T; Mao F; Wang Y; Sun Q; Li R; Yang G; Zhang X; Luo J; Feng GS; Yang X
J Cell Sci; 2010 Mar; 123(Pt 5):682-9. PubMed ID: 20124419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
